Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial

To assess the effect and toxicity of hypotonic cisplatin treatment (HPT) consisting of the intrapleural administration of cisplatin in distilled water for malignant pleural effusion in patients with non-small-cell lung cancer (NSCLC). Non-small-cell lung cancer patients with cytologically proven and...

Descripción completa

Detalles Bibliográficos
Autores principales: Seto, T, Ushijima, S, Yamamoto, H, Ito, K, Araki, J, Inoue, Y, Semba, H, Ichinose, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360516/
https://www.ncbi.nlm.nih.gov/pubmed/16940982
http://dx.doi.org/10.1038/sj.bjc.6603319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360516/
https://www.ncbi.nlm.nih.gov/pubmed/16940982
http://dx.doi.org/10.1038/sj.bjc.6603319

Ejemplares similares